Clinical Trials Directory

Trials / Completed

CompletedNCT04363710

Prospective Interventional Study on Reversibility of Type 2 Diabetes Mellitus With Hypocaloric Diet

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
33 (actual)
Sponsor
Max Healthcare Insititute Limited · Academic / Other
Sex
All
Age
35 Years – 60 Years
Healthy volunteers
Not accepted

Summary

T2DM, a chronic progressive disorder has an epidemic status in India. Remission (HbA1c of \< 6.5% without any anti-diabetic medication) of T2DM is achievable with diet modifications in recently diagnosed obese T2D individuals. Studies suggest Very Low Calorie Diet (600 - 800kcal) and Low Calorie Diet-LCD (800 -1000 kcal) using Meal replacers (MR) are helpful. The investigators aimed to study the effects of LCD without any anti diabetic medication in intervention group and later comparing it with Control group (on standard medical treatment).

Detailed description

The objective is to study the effect of LCD in anthropometric , biochemical and NAFLD (Non Alcholic Fatty Liver Disease) parameters after 8 weeks and 24 weeks from enrollment. Purposive sampling is used to enroll participants in the study. The LCD is a combination of one meal replacer and modified major meals. Calculated exchanges of food groups is taken care of in the other two major meals and snacks in between. Inorder to adhere compliance clinical (at baseline, after 8 weeks, after 24 weeks) as well as virtual visits through whatsapp, e-mails, SMS, phone calls (once a week during 8 weeks of intervention and further once a month upto 24 weeks) are scheduled. After 8 weeks of LCD, calorie is increased to 1200-1400 Kcal/day. In the control group the standard medical treatment is continued. The data is collected in case report form and analysed using SPSS software by statistician.

Conditions

Interventions

TypeNameDescription
OTHERLow Calorie Diet800-1000 Kcal/day

Timeline

Start date
2017-05-31
Primary completion
2018-06-01
Completion
2018-11-07
First posted
2020-04-27
Last updated
2020-04-27

Locations

1 site across 1 country: India

Source: ClinicalTrials.gov record NCT04363710. Inclusion in this directory is not an endorsement.